{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:01:14Z","timestamp":1780592474762,"version":"3.54.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.diagmicrobio.2021.115613","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:25:36Z","timestamp":1638271536000},"page":"115613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of the QuantiFERON-TB\u00ae Gold Plus on LIAISON\u00ae XL and T-SPOT.TB for the diagnosis of latent Mycobacterium tuberculosis infection in a low tuberculosis incidence population"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5912-9605","authenticated-orcid":false,"given":"Laura","family":"Heireman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Bruynseels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-8027","authenticated-orcid":false,"given":"Dieter","family":"Geysels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Huyghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja","family":"Van Gasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0001","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/JCM.02803-15","article-title":"Interferon gamma release assays for latent tuberculosis: what are the sources of variability?","volume":"54","author":"Banaei","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0002","first-page":"e00720","article-title":"QuantiFERON-TB Gold Plus with chemiluminescence immunoassay: do we need a higher cutoff?","volume":"22","author":"Bisognin","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0003","first-page":"343","article-title":"Comparative evaluation of CLIA and EIA for Quantiferon-TB Gold Plus","volume":"128","author":"Brantestig","year":"2020","journal-title":"J Pathol Microbiol Immunol"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0004","article-title":"Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results","volume":"26","author":"Brown","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0005","first-page":"e00120","article-title":"Evaluation of quantiFERON-TB\u00ae gold plus on LIAISON\u00ae XL in a low tuberculosis incidence setting","volume":"58","author":"Demaertelaere","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0006","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0007","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jiac.2017.09.012","article-title":"Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis","volume":"24","author":"Igari","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0008","doi-asserted-by":"crossref","first-page":"e2665","DOI":"10.1371\/journal.pone.0002665","article-title":"Interferon-gamma release assay for the diagnosis of latent TB infection \u2013 analysis of discordant results, when compared to the tuberculin skin test","volume":"3","author":"Nienhaus","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0009","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jiac.2017.10.009","article-title":"Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan","volume":"24","author":"Takasaki","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0010","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jiac.2020.06.019","article-title":"Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB among patients with tuberculosis","volume":"26","author":"Takeda","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0011","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/17476348.2014.852471","article-title":"Interferon-gamma release assays for tuberculosis: current and future applications","volume":"8","author":"Thillai","year":"2014","journal-title":"Exp Revi Respirat Med"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0012","doi-asserted-by":"crossref","first-page":"601737","DOI":"10.1155\/2013\/601737","article-title":"Interferon-gamma release assays vtuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence","volume":"2013","author":"Trajman","year":"2013","journal-title":"Pulmonary Med"},{"key":"10.1016\/j.diagmicrobio.2021.115613_bib0013","doi-asserted-by":"crossref","first-page":"e01420","DOI":"10.1128\/JCM.01436-20","article-title":"QuantiFERON-TB Gold Plus: high qualitative and quantitative agreement between enzyme-linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA)","volume":"58","author":"Villalta","year":"2020","journal-title":"J Clin Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321003047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321003047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:57:13Z","timestamp":1760003833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889321003047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0732889321003047"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115613","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the QuantiFERON-TB\u00ae Gold Plus on LIAISON\u00ae XL and T-SPOT.TB for the diagnosis of latent Mycobacterium tuberculosis infection in a low tuberculosis incidence population","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115613"}}